Richardson is a Board-certified toxicologist specializing in the development and implementation of nonclinical strategies to support drug candidate selection, IND filing, clinical development and NDA/BLA submissions. Experience encompasses biological, small molecule and oligonucleotide-based therapeutics and preclinical to Phase 3 compounds. Specialties: Seasoned team leader/player who thrives in dynamic, cross-functional environments and has proven expertise in the management of research groups, cross-functional project teams and contract service providers. Excellent communicator, mentor and coach.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)